BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16281462)

  • 1. Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study.
    Sydes MR; Altman DG; Babiker AB; Parmar MK; Spiegelhalter DJ;
    Clin Trials; 2004 Feb; 1(1):48-59. PubMed ID: 16281462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting on data monitoring committees in neonatal randomised controlled trials is inconsistent.
    Perrem LM; Gosling S; Ravikumar I; Khashan AS; Miletin J; Ryan CA; Dempsey E
    Acta Paediatr; 2017 Jan; 106(1):30-33. PubMed ID: 27637413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues in data monitoring and interim analysis of trials.
    Grant AM; Altman DG; Babiker AB; Campbell MK; Clemens FJ; Darbyshire JH; Elbourne DR; McLeer SK; Parmar MK; Pocock SJ; Spiegelhalter DJ; Sydes MR; Walker AE; Wallace SA;
    Health Technol Assess; 2005 Mar; 9(7):1-238, iii-iv. PubMed ID: 15763038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data monitoring in randomized controlled trials: surveys of recent practice and policies.
    Clemens F; Elbourne D; Darbyshire J; Pocock S;
    Clin Trials; 2005; 2(1):22-33. PubMed ID: 16279576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials.
    Fernandes RM; van der Lee JH; Offringa M
    BMC Pediatr; 2009 Dec; 9():77. PubMed ID: 20003383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data monitoring committees, interim analysis and early termination in paediatric trials.
    Fernandes RM; van der Lee JH; Offringa M
    Acta Paediatr; 2011 Oct; 100(10):1386-92. PubMed ID: 21434998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias.
    Tharmanathan P; Calvert M; Hampton J; Freemantle N
    BMC Med Res Methodol; 2008 Mar; 8():12. PubMed ID: 18366697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reporting of data monitoring boards in publications of randomized clinical trials is often deficient: ACTTION systematic review.
    Gewandter JS; Kitt RA; Hunsinger MR; Poku J; Lozano J; Chaudari J; Evans S; Gross RA; McDermott MP; Rowbotham MC; Turk DC; Dworkin RH
    J Clin Epidemiol; 2017 Mar; 83():101-107. PubMed ID: 28126598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cohort examination to establish reporting of the remit and function of Trial Steering Committees in randomised controlled trials.
    Conroy EJ; Arch B; Harman NL; Lane JA; Lewis SC; Norrie J; Sydes MR; Gamble C
    Trials; 2017 Dec; 18(1):590. PubMed ID: 29221458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of registered and published primary outcomes in randomized clinical trials of surgical interventions.
    Hannink G; Gooszen HG; Rovers MM
    Ann Surg; 2013 May; 257(5):818-23. PubMed ID: 23407296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposal.
    Dechartres A; Boutron I; Roy C; Ravaud P
    J Clin Epidemiol; 2009 Jul; 62(7):695-702. PubMed ID: 19135860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The handsearching of 2 medical journals of Bahrain for reports of randomized controlled trials.
    Al-Hajeri AA; Fedorowicz Z; Amin FA; Eisinga A
    Saudi Med J; 2006 Apr; 27(4):526-30. PubMed ID: 16598332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "You have to keep your nerve on a DMC." Challenges for Data Monitoring Committees in neonatal intensive care trials: Qualitative accounts from the BRACELET Study.
    Snowdon C; Brocklehurst P; Tasker RC; Ward Platt M; Elbourne D
    PLoS One; 2018; 13(7):e0201037. PubMed ID: 30048484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the independence of data monitoring committee in adaptive design clinical trials.
    Chow SC; Corey R; Lin M
    J Biopharm Stat; 2012; 22(4):853-67. PubMed ID: 22651119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals.
    Gabler NB; Duan N; Raneses E; Suttner L; Ciarametaro M; Cooney E; Dubois RW; Halpern SD; Kravitz RL
    Trials; 2016 Jul; 17(1):320. PubMed ID: 27423688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trials stopped early for benefit: a systematic review.
    Montori VM; Devereaux PJ; Adhikari NK; Burns KE; Eggert CH; Briel M; Lacchetti C; Leung TW; Darling E; Bryant DM; Bucher HC; Schünemann HJ; Meade MO; Cook DJ; Erwin PJ; Sood A; Sood R; Lo B; Thompson CA; Zhou Q; Mills E; Guyatt GH
    JAMA; 2005 Nov; 294(17):2203-9. PubMed ID: 16264162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Futility approaches to interim monitoring by data monitoring committees.
    Demets DL
    Clin Trials; 2006; 3(6):522-9. PubMed ID: 17170036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment effects monitoring committees and early stopping in large clinical trials.
    Kiri A; Tonascia S; Meinert CL
    Clin Trials; 2004 Feb; 1(1):40-7. PubMed ID: 16281461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The demise of the randomised controlled trial: bibliometric study of the German-language health care literature, 1948 to 2004.
    Galandi D; Schwarzer G; Antes G
    BMC Med Res Methodol; 2006 Jul; 6():30. PubMed ID: 16824217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reporting of Randomized Controlled Trials With Statistically Nonsignificant Primary Outcomes Published in High-impact Surgical Journals.
    Arunachalam L; Hunter IA; Killeen S
    Ann Surg; 2017 Jun; 265(6):1141-1145. PubMed ID: 27257737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.